Lidex: profile and news

(PZ) Medicis Announces FDA Approval of Broader Indication for ... Mar 2, 2006
...minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide ... - Houston Chronicle,

Medicis to Present at Merrill Lynch 17th Annual Global ... Feb 3, 2006
...minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide ... - Genetic Engineering News,

Medicis Board Unanimously Rejects Mentor Proposal Nov 20, 2005
...minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide ... - Business Wire (press release),

Medicis to Present at UBS Global Life Sciences Conference Sep 26, 2005
...minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide ... - PharmaLive.com (press release),

Medicis to Present at Thomas Weisel Partners Healthcare Tailwinds ... Sep 6, 2005
...minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide ... - Business Wire (press release),

Medicis to Present at Banc of America Securities 2005 Specialty ... Jul 25, 2005
...minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide ... - Business Wire (press release) <**results**>

Medicis Declares Cash Dividend Jun 15, 2005
...minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide ... - Business Wire (press release),

Medicis Reports Third Quarter Fiscal 2005 Financial Results Apr 21, 2005
...minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide ... - PharmaLive.com,

Medicis' psoriasis treatment gets FDA approval Feb 16, 2005
Inc in Canada, is a patented corticosteroid cream formulation for once or twice daily application which embodies the heritage of Lidex (fluocinonide), the ... - Pharmaceutical Business Review

Medicis Announces FDA Approval of Its NDA for VANOS, a Patented ... Feb 14, 2005
VANOS(TM) is a patented corticosteroid formulation which embodies the heritage of LIDEX(R), the number six most recognized dermatology brand in North America.(1 ... - Business Wire (press release),

Medicis Announces FDA Approval of AMMONUL for Urea Cycle Disorder Feb 18, 2005
...minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R) (sodium sulfacetamide/sulfur), TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide ... - Business Wire (press release),